Warby Parker director Raider sells $635k in shares

Director Jeffrey Jacob Raider sold 25,000 Warby Parker (WRBY) shares on March 11, 2026 for roughly $635,750 at $25.17–$25.69; post-sale he directly owns 448,697 shares and indirectly 2,170,571 shares. Warby Parker reported Q4 2025 EPS of -$0.05 vs $0.05 expected (negative surprise ~200%), with revenue $211.97M vs $213.11M consensus. Piper Sandler kept an Overweight rating with a $32 price target, while InvestingPro flags WRBY as overvalued with analyst targets from $18 to $35; company quarter-to-date revenue guidance of 6.5%–7.5% is below sell-side double-digit expectations and EBITDA missed due to weaker gross margins.

Analysis

Warby faces a classic scale/margin squeeze: an omnichannel player with significant fixed-store overhead competing against deeper-pocket incumbents and low-cost online sellers. Second-order winners are large lens and frame manufacturers (pricing power) and owners of scale logistics who can demand longer payment terms; losers include small independent optometrists who may see more aggressive promotions and margin-stealing price cuts.

The near-term risk window is concentrated: consumer discretionary softness and elevated inventory/markdown risk can compress gross margins sharply over the next 1-3 quarters, while successful remediation (pricing, SKU rationalization, store footprint optimization) would take 3-9 months to show in EBITDA. Key catalysts that will move the tape are quarter-to-quarter gross-margin trajectory, inventory days and promotional cadence, and any announced cost actions or capital injections; reversal scenarios include a faster-than-expected gross-margin rebound or a strategic buyer stepping in.

Consensus appears to underweight operational levers that can be executed quickly (targeted price increases on private-label lenses, higher-margin Rx services in-store, accelerated SKU pruning) and also overestimates the company’s ability to grow without renewed marketing efficiency. That asymmetry supports a bifurcated playbook: disciplined, time-boxed downside exposure with hedges, plus a small, event-driven long if indicators of margin repair appear (fewer promotions, lower inventory growth).

Key Decisions for Investors

• Short WRBY equity (3-6 month horizon): target 25-35% downside; position size 1-3% of portfolio. Use a hard stop at 15% adverse move and scale into weakness on any acceleration in markdowns or negative guidance. Catalysts: next two quarterly reports and inventory updates.
• Pair trade (6-12 months): short WRBY / long ELSFY (EssilorLuxottica OTC) to capture scale-driven margin dispersion. Use 1:0.25 notional to approximate margin exposure; target 30% relative outperformance of ELSFY vs WRBY, stop if the pair moves 15% against you.
• Options hedge (3-month): buy WRBY put spread (deep-to-mid OTM) sized to risk 0.5-1% portfolio to cap downside while keeping capital efficiency. Structure: buy longer-dated puts and sell closer strikes to finance ~50-70% of premium; profit if markdown-driven downside occurs.
• Event-driven long (6-9 months, small allocation 0.5-1%): buy a limited call spread only after visible operational fixes (sequential gross-margin improvement + shrinking inventory days). This asymmetric gamble converts into a high-reward play if remediation is credible.